Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
Stopped NINDS DSMB recommended trial be terminated for futility after reviewing an interim analysis of 84 subjects.
Conditions
- Amyotrophic Lateral Sclerosis
Interventions
- DRUG: Lithium Carbonate
- DRUG: Riluzole
- DRUG: placebo
Sponsor
Massachusetts General Hospital
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]